Skip to main content
PLOS Digital Health logoLink to PLOS Digital Health
. 2025 Feb 5;4(2):e0000524. doi: 10.1371/journal.pdig.0000524

Community perspectives regarding brain-computer interfaces: A cross-sectional study of community-dwelling adults in the UK

Austen El-Osta 1,*, Mahmoud Al Ammouri 1, Shujhat Khan 2, Sami Altalib 1, Manisha Karki 1, Eva Riboli-Sasco 1, Azeem Majeed 3
Editor: Avinash Singh4
PMCID: PMC11798465  PMID: 39908280

Abstract

Background

Brain-computer interfaces (BCIs) represent a ground-breaking advancement in neuroscience, facilitating direct communication between the brain and external devices. This technology has the potential to significantly improve the lives of individuals with neurological disorders by providing innovative solutions for rehabilitation, communication and personal autonomy. However, despite the rapid progress in BCI technology and social media discussions around Neuralink, public perceptions and ethical considerations concerning BCIs—particularly within community settings in the UK—have not been thoroughly investigated.

Objective

The primary aim of this study was to investigate public knowledge, attitudes and perceptions regarding BCIs including ethical considerations. The study also explored whether demographic factors were related to beliefs about BCIs increasing inequalities, support for strict regulations, and perceptions of appropriate fields for BCI design, testing and utilization in healthcare.

Methods

This cross-sectional study was conducted between 1 December 2023 and 8 March 2024. The survey included 29 structured questions covering demographics, awareness of BCIs, ethical considerations and willingness to use BCIs for various applications. The survey was distributed via the Imperial College Qualtrics platform. Participants were recruited primarily through Prolific Academic’s panel and personal networks. Data analysis involved summarizing responses using frequencies and percentages, with chi-squared tests to compare groups. All data were securely stored and pseudo-anonymized to ensure confidentiality.

Results

Of the 950 invited respondents, 846 participated and 806 completed the survey. The demographic profile was diverse, with most respondents aged 36–45 years (26%) balanced in gender (52% female), and predominantly identifying as White (86%). Most respondents (98%) had never used BCIs, and 65% were unaware of them prior to the survey. Preferences for BCI types varied by condition. Ethical concerns were prevalent, particularly regarding implantation risks (98%) and costs (92%). Significant associations were observed between demographic variables and perceptions of BCIs regarding inequalities, regulation and their application in healthcare. Conclusion: Despite strong interest in BCIs, particularly for medical applications, ethical concerns, safety and privacy issues remain significant highlighting the need for clear regulatory frameworks and ethical guidelines, as well as educational initiatives to improve public understanding and trust. Promoting public discourse and involving stakeholders including potential users, ethicists and technologists in the design process through co-design principles can help align technological development with public concerns whilst also helping developers to proactively address ethical dilemmas.

Author summary

Brain-computer interfaces (BCIs) are emerging technologies that enable direct communication between the brain and external devices, showing promise for enhancing healthcare, especially for individuals with neurological conditions. However, despite their potential, public understanding of BCIs remains limited. This study explored community perspectives on BCIs in the UK, focusing on awareness, ethical concerns and potential applications. A survey of 806 community-dwelling adults revealed that most participants were unfamiliar with BCIs, with only a small percentage having prior experience. Respondents showed strong interest in BCIs for medical purposes, such as rehabilitation for stroke or paralysis, while expressing significant concerns about their ethical implications, including privacy, safety and the risk of exacerbating social inequalities. Participants also emphasized the importance of clear regulatory frameworks and greater public education to build trust in the technology. Notably, demographic factors such as age, gender and education influenced participants’ views on the benefits and risks of BCIs. The findings highlight the need for further research to address public concerns and ensure that BCI development aligns with societal values and expectations.

Introduction

Brain-computer interfaces (BCIs) translate electrical signals from the brain into digital commands that can be interpreted by computers. BCIs represent a rapidly evolving field that stands at the intersection of neuroscience, engineering and medicine and has the potential to transform clinical care and enhance human capabilities [1].

In the last decade, significant progress has been made in BCI technology, with multiple studies demonstrating functional restoration in neurologically impaired individuals, particularly those suffering from conditions such as stroke, trauma and degenerative disorders leading to permanent disabilities [24]. Examples include providing an avenue for tetraplegic individuals to communicate through neural decoding to convert speech to text as well as prosthetics that enable movement [57]. BCIs can also be used in combination with functional electrical stimulation (FES) to enhance the rehabilitation process [3]. Similarly, in traumatic spinal cord injury, disruption of the neural signal from the brain to the skeletal muscles can be mitigated by connection with FES or an exoskeleton [4,8,9]. In addition to restorative capabilities, BCIs have been explored for enhancement and entertainment purposes. Examples include improving cognition, memory and strength, as well as connection with digital devices or prosthetics [10].

Beyond clinical applications, BCIs hold the potential to redefine human interaction with technology. The development of BCIs for communication in patients with locked-in syndrome—a complex medical condition presenting with quadriplegia and whole-body sensory loss [11]—illustrates the technology’s ability to bridge gaps in human communication [12]. However, current limitations in speed and accuracy highlight the need for ongoing research and development to enhance the interface’s reliability for broader applications, including virtual reality and neuroprosthetics [7,13]. The future of BCIs lies in refining these interfaces to achieve faster, more accurate communication and control, which would expand their clinical use and open new realms of human-computer interaction.

Whereas recent advancements in BCI technology highlight the potential for substantial therapeutic gains and enhanced human capabilities [14,15], as BCIs become increasingly sophisticated, the ethical implications of their use, particularly in non-medical contexts, warrant careful consideration [1416]. The prospect of BCIs for cognitive and motor enhancement also raises questions about privacy, data security and the potential for exacerbating social inequalities [17]. The potential integration of BCIs with cloud computing and the use of sensitive neural data for commercial purposes also highlights an urgent need for robust ethical guidelines and regulatory frameworks to safeguard individual rights and privacy [18].

Whilst invasive BCI technology has been aimed at the treatment of clinical disorders [19], the heterogeneity in BCI technology that is currently entering FDA trials suggests that the chronic effects will vary according to the individual surgical process. Further, the use of BCIs for enhancement aimed at surpassing natural human capabilities also poses ethical concerns especially when enhancements are aimed at surpassing natural human capabilities [14,20].

Because public perceptions of BCIs are mixed [2123], understanding public attitudes including concerns about ethical implications and societal impacts is crucial for guiding the responsible development and use of these technologies that aligns with societal values and expectations. The primary aim of this study was to investigate the knowledge, attitudes and perceptions of community-dwelling adults regarding BCIs. We also sought to uncover ethical considerations and gauge public interest in potential medical and non-medical applications. Additionally, the research explored whether demographic factors were associated with beliefs about BCIs increasing inequalities, support for strict regulations, and perceptions of appropriate fields for BCI design, testing and utilization in healthcare.

Materials and methods

Study design

We conducted a cross-sectional study among community-dwelling adults in the UK exploring the knowledge, attitudes, and perceptions regarding BCIs. The study adopted a quantitative methodology using an electronic survey (eSurvey).

The link to the electronic survey was active on the Imperial College Qualtrics platform between 1 December 2023 and 8 Mar 2024. The voluntary survey, which required less than 10 minutes to complete, was open and could be accessed by anyone with a link. Study information was disseminated including the Participant Information Sheet (PIS) and link to the survey. The researcher’s personal and professional networks were also mobilized to respond and further disseminate the eSurvey among potentially eligible participants. The majority of our participants were recruited via Prolific Academic’s panel, an online platform where researchers can make their surveys available to participants from specific demographic backgrounds [24]. This study employed a convenience sampling approach, as this allowed data collection from individuals who were readily accessible and willing to participate. We calculated the sample size using Raosoft online software [25] with 5% margin of error, 95% confidence interval and 50% response distribution, which resulted in a recommended sample size of 385 participants.

The PIS included information regarding the study’s aims, the protection of participants’ personal data, their right to withdraw from the study at any time, which data were stored, where and for how long, who the investigator was, the purpose of the study and survey length. Participants were informed that this was a voluntary survey without any monetary incentives but offering the possibility to access the findings at a later stage whilst underlying the potential collective benefits of taking part in terms of helping advance knowledge in this area. Data collected were stored on a secure database at Imperial College London and only the team researchers could access the eSurvey results. All responses were pseudo-anonymised to ensure confidentiality by assigning each respondent a unique study ID. Only the participants’ demographic data including age in years, gender, ethnicity, religion, residence, disability, education and employment status were recorded.

Electronic survey

The survey comprised a structured questionnaire designed to gauge community perspectives on BCIs within the UK. It featured sections on demographic information, awareness and understanding of BCIs, ethical considerations, and willingness to use BCIs for both medical and non-medical purposes. The questionnaire was reviewed by two academic expert researchers to determine its suitability, consistency and validity. The questionnaire was also piloted with 25 eligible participants who were subsequently removed from the study. Feedback from experts was utilized to revise the questionnaire to improve design and flow and to eliminate any ambiguity. The data collected during this initial pilot was not included in the final analysis.

The survey comprised a total of 29 questions distributed over 10 pages. To enhance the survey completion rate, a maximum of three items were displayed on any one survey page. The survey (S1 File) was accessible using a personal computer or smartphone by following this link:

https://imperial.eu.qualtrics.com/jfe/form/SV_6m866WMXceZ9pf8

The survey was distributed online, and was accessible via various platforms including LinkedIn, Twitter/X and the Prolific Academic Panel. The survey aimed to capture a broad spectrum of opinions from a diverse cross-section of adults residing in the UK. Respondents were able to review their answers before submitting them (through a back button). The first question after the survey introduction asked participants to confirm their consent to participate in the eSurvey. Participants were then asked questions through the survey that were anonymised and not personally identifiable. The online survey technical functionality was tested before being published.

All survey items were conditional and required a response. Respondents were prompted to complete outstanding items before leaving the survey page on which the item was contained. Most items included a ‘None of above/ prefer not to say’ option. Relevant survey items were displayed based on previous responses (e.g., only those who have used a BCI were shown the follow-up questions about the type of BCI technology they have been using). Certain items were also populated based on previous responses. To prevent participants from completing the survey more than once, Qualtrics XM places a browser cookie upon response submission, barring repeat attempts. Similarly, Prolific utilizes digital fingerprinting and geo-IP traps to enforce single survey completion.

Data analysis

Quantitative data were collected using an eSurvey questionnaire administered on Qualtrics XM. Survey responses were summarised using frequencies and percentages. Chi-squared test was used to compare groups. A p-value <0.05 was considered statistically significant.

To meet the assumptions of the chi-square test for inferential analysis [26], we combined certain categories within the variables. In the Religion variable, Hinduism, Buddhism and Sikhism were merged into a single category named Dharmic faiths [27]. Similarly, in the Education variable, ’Primary school and Secondary school up to 16 years’ were merged into one category. Additionally, the ’Yes with paralysis’ and ’Yes without paralysis’ categories in the disability-related variables were combined into ’Yes.’ In addition, we also excluded ’Prefer not to say’ responses and the ’non-binary’ category from the Gender variable, as there was only one participant in the latter for the inferential analysis. Respondents were not excluded from the survey if they completed the items too quickly. The minimum completed survey was timed at approximately 4 minutes. Only completed questionnaires were included in the final dataset.

All analyses were performed using STATA, version 17 (StataCorp LP, College Station, TX, USA). The Checklist for Reporting Results of Internet E-Surveys (CHERRIES) was used to guide reporting [28]; S2 File.

Ethical approval

The Imperial College Research Ethics Committee granted ethical clearance for the study (ICREC# 6887726). All experimental protocols were approved by Imperial College London Research Ethics Committee. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All subjects provided consent by selecting the relevant tick box at the start of the online survey. Consent for publication is not applicable.

Patient and public involvement

No patient was involved.

Results

Demographic profile of respondents

Of 950 potential respondents who were invited to participate in the survey, 846 engaged with the survey questions (89.1% participation rate), and 806 completed the survey (95.3% completion rate; 84.8% response rate). Included participants were diverse in age, gender, ethnicity and educational background (S1 Table). The largest proportion of respondents were in the 36–45-year (26.4%) and 26–35 (26.2%) age groups. Gender distribution was balanced with 51.6% identifying as female and 47.9% as male. Most participants identified as White (85.6%), followed by those from Asian/Asian British (7.2%) and British Black/African/Caribbean (4.6%) backgrounds. Less than a quarter (23.7%) identified as Christian, while the majority (66.7%) identified as atheists. The perceived importance of religion in life varied, with more than two-thirds (69.0%) considering it unimportant, 14.5% stating it was neither important nor unimportant, and 16.5% deeming it important. Most respondents resided in England (84.8%). A minority (10.8%) reported having a disability without paralysis, while 23.3% had a friend or relative with a non-paralytic disability. Two-thirds (66.5%) held a college or university degree, 55.6% were employed full-time and 18.5% were in part-time employment (S1 Table). The main survey results are shown in Table 1, and the underlying data file is included S3 File

Table 1. Survey Findings.

N (%)
Have you ever used a Brain-Computer Interface (BCI)?
    Yes, I am currently using one 6 (0.7)
    Yes, but I no longer use it 7 (0.9)
    No, never 793 (98.4)
What type of BCI technology have you been using? *
    Electroencephalography (EEG) 2 (12.5)
    Magnetoencephalography (MEG) 2 (12.5)
    Microelectrode arrays (MEAs) 1 (6.3)
    Functional magnetic resonance imaging (fMRI) 7 (43.7)
    Electrocorticography (ECoG), a type of intracranial electroencephalography (iEEG) 2 (12.5)
    I’m not sure 2 (12.5)
For what purpose have you been using a BCI? *
    For medical purposes 9 (64.3)
    For non-medical purposes 5 (35.7)
How much do you know about BCIs?
    I don’t know much but I have already heard of BCIs 276 (34.2)
    I know a lot about BCIs 7 (0.9)
    Nothing, I had never heard of BCIs before 523 (64.9)
Which of the following BCI devices have you heard about? *
    Hearing aid with brain implant component 163 (46.8)
    Neuralink (Owned by Elon Musk) 161 (46.3)
    Synchron (Stentrode) 7 (2.0)
    Others 17 (4.9)
Which of the following BCI technologies have you heard about? *
    Electroencephalography (EEG) 119 (28.2)
    Magnetoencephalography (MEG) 25 (5.9)
    Microelectrode arrays (MEAs) 22 (5.2)
    Functional magnetic resonance imaging (fMRI) 121 (28.7)
    Electrocorticography (EcoG), a type of intracranial electroencephalography (iEEG) 25 (5.9)
    None of the above 110 (26.1)
Where have you heard or read about BCIs? *
    In the news (on TV, radio, online or printed newspaper) 212 (44.5)
    On online forums 69 (14.5)
    From friends & family 44 (9.2)
    From colleagues at work 34 (7.1)
    From my GP, nurse, or another healthcare professional 23 (4.8)
    Through advertisement 12 (2.5)
    In the scientific literature 57 (12.0)
    Other 25 (5.4)
In which of the following fields do you think BCIs are already being used? *
    Health care & assistive technology (e.g.: to support patients with paralysis or for stroke rehabilitation) 719 (38.6)
    Education & learning (e.g.: to address learning disabilities) 364 (19.5)
    Entertainment & recreational use (e.g.: for gaming or sports) 191 (10.3)
    Workplace (e.g.: to track & improve productivity) 122 (6.6)
    Marketing & commerce (e.g.: for targeted advertisement & personalised needs assessments) 103 (5.5)
    Military, police & security use (e.g.: lie detection) 357 (19.2)
    Other 6 (0.3)
In which of the following fields do you think BCIs are currently being designed & tested (still at the experimental stage & not yet being used)? *
    Health care & assistive technology (e.g.: to support patients with paralysis, stroke rehabilitation) 443 (19.3)
    Education & learning (e.g.: to address learning disabilities) 426 (18.6)
    Entertainment & recreational use (e.g.: gaming, sports) 370 (16.2)
    Workplace (e.g.: to track & improve productivity) 356 (15.6)
    Marketing & commerce (e.g.: for targeted advertisements & personalised needs assessments) 287 (12.5)
    Military, police & security use (e.g.: lie detection) 403 (17.6)
    Other 4 (0.2)
In which of the following fields do you think BCIs should be designed, tested & used? *
    Health care & assistive technology (e.g.: to support patients with paralysis, stroke rehabilitation) 751 (31.9)
    Education & learning (e.g.: to address learning disabilities) 633 (26.8)
    Entertainment & recreational use (e.g.: gaming, sports) 244 (10.3)
    Workplace (e.g.: to track & improve productivity) 206 (8.7)
    Marketing & commerce (e.g.: for targeted advertisements & personalised needs assessments) 108 (4.6)
    Military, police & security use (e.g.: lie detection) 412 (17.5)
    Other 4 (0.2)
What type of BCI would you personally consider using? *
Complete paralysis
    Invasive 632 (57.4)
    Non-invasive 409 (37.1)
    I would not consider using any BCI 61 (5.5)
Partial paralysis
    Invasive 489 (46.4)
    Non-invasive 501 (47.6)
    I would not consider using any BCI 63 (6.0)
Weakness in my arms or legs
    Invasive 174 (19.2)
    Non-invasive 633 (69.8)
    I would not consider using any BCI 100 (11.0)
Stroke rehabilitation
    Invasive 329 (33.6)
    Non-invasive 598 (61.1)
    I would not consider using any BCI 52 (5.3)
Speech impediment
    Invasive 221 (24.2)
    Non-invasive 593 (65.0)
    I would not consider using any BCI 98 (10.8)
Visual impairment
    Invasive 330 (34.0)
    Non-invasive 554 (57.0)
    I would not consider using any BCI 88 (9.0)
Lack of control of my bladder
    Invasive 312 (32.1)
    Non-invasive 543 (55.9)
    I would not consider using any BCI 117 (12.0)
Lack of control of my bowels
    Invasive 343 (35.0)
    Non-invasive 531 (54.0)
    I would not consider using any BCI 108 (11.0)
Parkinson’s disease
    Invasive 525 (49.8)
    Non-invasive 472 (44.7)
    I would not consider using any BCI 58 (5.5)
Attention-deficit hyperactivity disorder (ADHD)
    Invasive 99 (11.5)
    Non-invasive 493 (57.4)
    I would not consider using any BCI 267 (31.1)
Dementia
    Invasive 416 (41.1)
    Non-invasive 517 (51.0)
    I would not consider using any BCI 80 (7.9)
Depression
    Invasive 92 (10.6)
    Non-invasive 483 (55.9)
    I would not consider using any BCI 289 (33.5)
Anxiety
    Invasive 69 (8.1)
    Non-invasive 465 (54.9)
    I would not consider using any BCI 313 (37.0)
To enhance my physical abilities (strength, speed)
    Invasive 85 (10.0)
    Non-invasive 305 (35.7)
    I would not consider using any BCI 463 (54.3)
To enhance my cognitive abilities (memory, attention, etc)
    Invasive 103 (12.0)
    Non-invasive 390 (45.5)
    I would not consider using any BCI 364 (42.5)
Would you consider getting a BCI for any other reason not listed above?
    Yes 38 (4.7)
    No 768 (95.3)
What would prevent you from getting an invasive BCI (requiring a surgical procedure)? *
    High cost of buying & maintaining the device 541 (12.0)
    Stigma of having a medical device implanted 93 (2.1)
    Complexity & risk of the surgical procedure to IMPLANT the BCI 595 (13.2)
    Complexity & risk of the surgical procedure to REMOVE the BCI 518 (11.5)
    Postoperative care (including attending further appointments) 234 (5.2)
    Risks in case the BCI stops working or malfunctions 499 (11.0)
    Limited effectiveness of the BCI 226 (5.0)
    Concern the BCI may alter my personality 246 (5.4)
    Concern the BCI may alter my mood 203 (4.5)
    Lack of evidence & historical perspective regarding BCIs 479 (10.6)
    Enabling further access to personal data 169 (3.7)
    Risk of hacking of the device 289 (6.4)
    General distrust in BCIs & the companies selling them 190 (4.2)
    Aesthetics (it may not look good) 146 (3.2)
    Lack of support or agreement from my family & friends 58 (1.3)
    Lack of support or agreement from my religious community 22 (0.5)
    Other 10 (0.2)
How important are the following factors in influencing your decision to get an invasive BCI? **
High cost of buying & maintaining the device
    Unimportant 6 (1.3)
    Neither important nor unimportant 33 (7.0)
    Important 433 (91.7)
Stigma of having a medical device implanted
    Unimportant 8 (9.6)
    Neither important nor unimportant 24 (28.9)
    Important 51 (61.5)
Complexity & risk of the surgical procedure to IMPLANT the BCI
    Unimportant 2 (0.4)
    Neither important nor unimportant 10 (2.0)
    Important 501 (97.6)
Complexity & risk of the surgical procedure to REMOVE the BCI
    Unimportant 4 (0.9)
    Neither important nor unimportant 9 (2.0)
    Important 434 (97.1)
Postoperative care (including attending further appointments)
    Unimportant 99 (47.7)
    Neither important nor unimportant 2 (1.0)
    Important 106 (51.2)
Risks in case the BCI stops working or malfunctions
    Unimportant 4 (0.9)
    Neither important nor unimportant 10 (2.3)
    Important 420 (96.8)
Limited effectiveness of the BCI
    Unimportant 1 (0.5)
    Neither important nor unimportant 12 (6.1)
    Important 183 (93.4)
Concern the BCI may alter my personality
    Unimportant 7 (3.2)
    Neither important nor unimportant 10 (4.6)
    Important 202 (92.2)
Concern the BCI may alter my mood
    Unimportant 3 (1.6)
    Neither important nor unimportant 12 (6.5)
    Important 171 (91.9)
Lack of evidence & historical perspective regarding BCIs
    Unimportant 4 (1.0)
    Neither important nor unimportant 35 (8.3)
    Important 382 (90.7)
Enabling further access to personal data
    Unimportant 9 (6.1)
    Neither important nor unimportant 16 (10.9)
    Important 122 (83.0)
Risk of hacking of the device
    Unimportant 100 (40.2)
    Neither important nor unimportant 6 (2.4)
    Important 143 (57.4)
General distrust in BCIs & the companies selling them
    Unimportant 6 (3.7)
    Neither important nor unimportant 12 (7.3)
    Important 146 (89.0)
Aesthetics (it may not look good)
    Unimportant 8 (6.2)
    Neither important nor unimportant 21 (16.3)
    Important 100 (77.5)
Lack of support or agreement from my family & friends
    Unimportant 3 (6.1)
    Neither important nor unimportant 9 (18.4)
    Important 37 (75.5)
Lack of support or agreement from my religious community
    Unimportant 3 (17.7)
    Neither important nor unimportant 4 (23.5)
    Important 10 (58.8)
Other
    Unimportant 2 (22.2)
    Neither important nor unimportant 4 (44.5)
    Important 3 (33.3)
How long do you think it will be before BCIs become the new normal in the UK?
    Less than a year 4 (0.5)
    2 to 5 years 69 (8.6)
    6 to 10 years 177 (22.0)
    More than 10 years 396 (49.1)
    BCIs will never be used so broadly 160 (19.8)
To what extent do you agree with the following statements regarding BCIs in general (both invasive & non-invasive)?
“I’m worried about the effect of BCIs being widely available to the public”
    Disagree 216 (26.8)
    Neither agree nor disagree 240 (29.8)
    Agree 350 (43.4)
“I’m excited for the potential that BCIs can bring for society”
Disagree 141 (17.5)
Neither agree nor disagree 226 (28.0)
Agree 439 (54.5)
“People with BCIs will be more productive in their work”
    Disagree 162 (20.1)
    Neither agree nor disagree 438 (54.3)
    Agree 206 (25.6)
“People with BCIs will feel superior to those without”
    Disagree 291 (36.1)
    Neither agree nor disagree 297 (36.9)
    Agree 218 (27.0)
“BCIs will lead to an increase in inequalities”
    Disagree 189 (23.4)
    Neither agree nor disagree 294 (36.5)
    Agree 323 (40.1)
“I’m worried BCIs may be implanted without proper consent”
    Disagree 255 (31.6)
    Neither agree nor disagree 177 (22.0)
    Agree 374 (46.4)
“BCIs will increase stigmatisation & pathologisation of people with disability”
    Disagree 314 (39.0)
    Neither agree nor disagree 271 (33.6)
    Agree 221 (27.4)
“Use of invasive BCIs in healthy patients is morally wrong”
    Disagree 147 (18.2)
    Neither agree nor disagree 257 (31.9)
    Agree 402 (49.9)
“Invasive BCIs should be reserved to people with physical and/or cognitive disabilities”
    Disagree 88 (10.9)
    Neither agree nor disagree 195 (24.2)
    Agree 523 (64.9)
“I support strict regulation in the development & use of BCIs even if it means technological progress”
    Disagree 24 (3.0)
    Neither agree nor disagree 113 (14.0)
    Agree 669 (83.0)
“BCIs for medical purposes should be reimbursed by the NHS or insurance companies”
    Disagree 47 (5.8)
    Neither agree nor disagree 220 (27.3)
    Agree 539 (66.9)
“BCIs for healthy people should be reimbursed by the government or insurance companies”
    Disagree 458 (56.8)
    Neither agree nor disagree 200 (24.8)
    Agree 148 (18.4)
“BCIs should not be accessible to children (under 18 years old)”
    Disagree 152 (18.9)
    Neither agree nor disagree 269 (33.4)
    Agree 385 (47.7)

* = Multiple choice question (any unit of interest is number of answers and not the number of respondents)

** = non-conditional responses, carried forward from participants’ answers to the question: “What would prevent you from getting an invasive BCI (requiring a surgical procedure)?

† = Follow-up questions for those answered “Yes, I am currently using one” or “Yes, but I no longer use it” in question “Have you ever used a Brain-Computer Interface (BCI)?‡ = Follow-up questions for those answered “I know a lot about BCIs” or “I don’t know much but I have already heard of BCIs” in question “How much do you know about BCIs?

Current use and knowledge about BCIs

Only a small fraction (0.7%) reported current utilization of BCIs or reported past usage (0.9%); Table 1. Regarding BCI familiarity, only 0.9% had comprehensive knowledge, a third (34.2%) knew of BCIs but lacked detailed knowledge, whereas most (64.9%) were unaware of BCIs before the survey. Nearly half recognized hearing aids with brain implants (46.8%) and Neuralink (46.3%), but only a few knew about Synchron (2.0%) and other BCIs (4.9%). The best-known BCI technologies were EEG (28.2%) and fMRI (28.7%). Main information sources were news outlets (44.5%), online forums (14.5%) and scientific literature (12.0%), with less input from friends, family, colleagues, healthcare professionals and advertisements.

Preferences for BCI types to tackle impediments

Participants showed different preferences for BCI types based on various conditions. In cases of complete paralysis, 57.4% preferred invasive BCIs, 37.1% favoured non-invasive options and 5.5% showed no interest in BCIs (Table 1). For partial paralysis, 46.4% would choose invasive, 47.6% non-invasive and 6.0% would not consider using any BCI. When considering weakness in arms or legs, the majority (69.8%) opted for non-invasive BCIs, 19.2% for invasive and 11.0% expressed no interest. For stroke rehabilitation, 61.1% preferred non-invasive, 33.6% invasive and 5.3% showed no interest in using any of the BCI types. Preferences for BCIs also varied for conditions like speech impediments, visual impairment, bladder and bowel control issues, Parkinson’s disease, ADHD, dementia, depression and anxiety, and for enhancing physical or cognitive abilities (Table 1).

Interest and acceptability for current and future applications of BCIs

Over a third of respondents (38.6%) believed BCIs were currently used in healthcare and assistive technology, 19.5% in education, 10.3% in entertainment, 6.6% in workplaces, 5.5% in marketing and 19.2% in military and security sectors (Table 1). For BCIs in the experimental stages, 19.3% considered healthcare as the primary area for BCI development, followed by education (18.6%), military (17.6%) and entertainment (16.2%). Prospects favoured healthcare (31.9%) and education (26.8%), with lower support for military (17.5%) and entertainment (10.3%). Fewer advocated BCIs for workplace (8.7%) and marketing purposes (4.6%); Fig 1.

Fig 1. Bar chart comparing public perceptions of BCIs applications in different fields across three categories: current use (orange), experimental stage (blue) and desired future use (green).

Fig 1

Ethical and social concerns

The main deterrents to using BCIs were the complexity and risk of implantation (13.2%) and high costs (12.0%); Table 1. Other concerns included malfunction risks (11.0%), removal complexities (11.5%) and lack of historical evidence (10.6%). Lesser worries were hacking risks (6.4%), postoperative care (5.2%) and limited effectiveness (5.0%). Less prevalent concerns were personality changes (5.4%), lack of family support (1.3%) and aesthetic issues (3.2%); Fig 2.

Fig 2. Funnel chart of the perceived barriers to adopting BCIs, ranked by percentage of concern among respondents.

Fig 2

Most respondents found the risks of implanting (97.6%) and removing (97.1%) BCIs significant. Concerns about malfunctions (96.8%) and effectiveness (93.4%) were high, whereas perceived high costs (91.7%), mood impacts (92.2%) and historical data deficits (90.7%) were also notable. Hacking risks (57.4%), aesthetic (77.5%) and family support issues (75.5%) were also significant, with lower religious community support (58.8%).

Views on the impact of BCIs on productivity and inequality were mixed; 54.3% were neutral and 40.1% considered that BCIs may exacerbate inequalities. Concerns included stigma and consent, with 64.9% supporting use for disabilities, and 83.0% endorsing strict regulations. Two-thirds supported medical BCI reimbursements, while 56.8% opposed non-medical reimbursements. While 54.5% were excited about societal benefits of BCIs, 43.4% had availability concerns, and less than half (47.7%) supported BCIs for minors.

Associations between demographics and the belief that BCIs will lead to an increase in inequalities

We found a significant association between age and the belief that BCIs will lead to an increase in inequalities (p < 0.001). Younger individuals (aged 26–35) demonstrated a higher tendency to agree (31.3%) compared to older age groups, particularly those aged 66 and older who showed a much lower agreement rate (2.1%); Table 2. There was also a significant association with gender (p = 0.035). Among females, 50.9% agreed that BCIs would increase inequalities, while males showed a slightly lower agreement rate of 49.1%. Neither ethnicity (p = 0.400) nor religion (p = 0.005) yielded a significant association, although 72.3% with no religion agreed that BCIs would exacerbate disparities. Conversely, education (p = 0.019), knowing someone with a disability (p = 0.015), and employment status (p = 0.011), were significantly associated with the belief that BCI will lead to an increase in inequalities.

Table 2. Associations between demographics and the belief that BCIs will lead to an increase in inequalities.

Disagree; n (%) Neither agree nor disagree; n (%) Agree; n (%) Total; n (%) p-value
Age <0.001
    18–25 17 (9.0) 26 (8.8) 57 (17.6) 100 (12.4)
    26–35 42 (22.2) 68 (23.1) 101 (31.3) 211 (26.2)
    36–45 50 (26.5) 79 (26.9) 84 (26.0) 213 (26.4)
    46–55 33 (17.5) 53 (18.1) 47 (14.6) 133 (16.5)
    56–65 24 (12.7) 48 (16.3) 27 (8.4) 99 (12.3)
    66 and Older 23 (12.1) 20 (6.8) 7 (2.1) 50 (6.2)
Gender 0.035
    Female 85 (45.2) 168 (57.1) 163 (50.9) 416 (51.9)
    Male 103 (54.8) 126 (42.9) 157 (49.1) 386 (48.1)
Ethnicity 0.400
    White 166 (88.3) 254 (86.7) 270 (84.1) 690 (86.0)
    Mixed/Multiple ethnic groups 5 (2.7) 3 (1.0) 3 (0.9) 11 (1.4)
    Asian/Asian British 9 (4.8) 20 (6.8) 29 (9.0) 58 (7.2)
    British Black/African/Caribbean 8 (4.2) 13 (4.4) 16 (5.1) 37 (4.6)
    Other 0 (0.0) 3 (1.0) 3 (0.9) 6 (0.8)
Religion 0.005
    Christian 63 (34.1) 69 (24.2) 59 (18.6) 191 (24.3)
    Dharmic (Hinduism, Buddhism or Sikhism) 1 (0.5) 6 (2.1) 11 (3.5) 18 (2.3)
    Islam 7 (3.8) 10 (3.5) 9 (2.8) 26 (3.3)
    No religion 113 (61.1) 196 (68.8) 229 (72.3) 538 (68.4)
    Other religion 1 (0.5) 4 (1.4) 9 (2.8) 14 (1.7)
Importance of religion in life 0.580
    Unimportant 122 (64.6) 207 (70.4) 227 (70.3) 556 (69.0)
    Neither important nor unimportant 33 (17.5) 42 (14.3) 42 (13.0) 117 (14.5)
    Important 34 (18.1) 45 (15.3) 54 (16.7) 133 (16.5)
Residence in the UK 0.410
    England 158 (83.6) 254 (86.4) 272 (84.2) 684 (84.8)
    Northern Ireland 6 (3.2) 5 (1.6) 5 (1.6) 16 (2.0)
    Scotland 13 (6.8) 23 (7.9) 34 (10.5) 70 (8.7)
    Wales 12 (6.4) 12 (4.1) 12 (3.7) 36 (4.5)
Disability 0.410
    No 167 (89.8) 258 (89.9) 276 (86.8) 701 (88.6)
    Yes (with or without paralysis) 19 (10.2) 29 (10.1) 42 (13.2) 90 (11.4)
Relative or friend with a disability 0.015
    No 133 (73.9) 218 (76.0) 205 (65.7) 556 (71.4)
    Yes (with or without paralysis) 47 (26.1) 69 (24.0) 107 (34.3) 223 (28.6)
Education 0.019
    Primary or secondary school up to 16 years 22 (11.7) 39 (13.3) 22 (6.9) 83 (10.4)
    Higher or secondary or further education (A-levels, BTEC, etc.) 52 (27.7) 64 (21.8) 66 (20.7) 182 (22.7)
    College or university degree 114 (60.6) 191 (64.9) 231 (72.4) 536 (66.9)
Employment status 0.011
    Employed full-time 103 (55.4) 158 (55.4) 187 (58.6) 448 (56.7)
    Employed part-time 36 (19.4) 56 (19.6) 57 (17.9) 149 (18.9)
    Retired 22 (11.8) 29 (10.2) 15 (4.7) 66 (8.4)
    Student 6 (3.2) 9 (3.2) 27 (8.5) 42 (5.2)
    Unemployed 19 (10.2) 33 (11.6) 33 (10.3) 85 (10.8)

Associations between demographics and supporting strict regulation in the development and the use of BCIs even if it means technological progress

Age was significantly associated with support for strict regulation in the development and use of BCIs (p = 0.022), where respondents aged 18–25 showed a higher percentage of agreement (10.8%) compared to older age groups, particularly those aged 66 and older who had a lower agreement rate of 7% (Table 3). Gender also demonstrated a significant association (p = 0.044), with 53.7% of females supporting strict regulation compared to 46.3% of males. Additionally, ethnicity was significantly associated with support for regulation (p = 0.004), as most White respondents (87.7%) agreed with the need for strict regulation, while only 1.2% of individuals from Mixed/Multiple ethnic groups supported it. Knowing someone with a disability (p = 0.010), and employment status (p = 0.004), were also significantly associated with support for strict regulation in the development and use BCIs.

Table 3. Associations between demographics and supporting strict regulation in the development and use of BCIs even if it means technological progress.

Disagree; n (%) Neither agree nor disagree; n (%) Agree; n (%) Total; n (%) p-value
Age 0.022
    18–25 7 (29.2) 21 (18.6) 72 (10.8) 100 (12.4)
    26–35 7 (29.2) 33 (29.2) 171 (25.6) 211 (26.2)
    36–45 6 (25.0) 32 (28.2) 175 (26.2) 213 (26.4)
    46–55 3 (12.4) 16 (14.2) 114 (17.0) 133 (16.5)
    56–65 1 (4.2) 8 (7.1) 90 (13.4) 99 (12.3)
    66 and Older 0 (0.0) 3 (2.7) 47 (7.0) 50 (6.2)
Gender 0.044
    Female 8 (33.3) 51 (45.1) 357 (53.7) 416 (51.9)
    Male 16 (66.7) 62 (54.9) 308 (46.3) 386 (48.1)
Ethnicity 0.004
    White 14 (60.9) 91 (81.3) 585 (87.7) 690 (86.0)
    Mixed/Multiple ethnic groups 1 (4.3) 2 (1.8) 8 (1.2) 11 (1.4)
    Asian/Asian British 6 (26.1) 8 (7.1) 44 (6.6) 58 (7.2)
    British Black/African/Caribbean 2 (8.7) 10 (8.9) 25 (3.8) 37 (4.6)
Other 0 (0.0) 1 (0.9) 5 (0.7) 6 (0.8)
Religion 0.080
    Christian 2 (9.5) 28 (25.7) 161 (24.5) 191 (24.3)
    Dharmic (Hinduism, Buddhism or Sikhism) 1 (4.8) 2 (1.8) 15 (2.3) 18 (2.3)
    Islam 3 (14.3) 6 (5.5) 17 (2.5) 26 (3.2)
    No religion 15 (71.4) 72 (66.1) 451 (68.7) 538 (68.4)
Other religion 0 (0.0) 1 (0.9) 13 (2.0) 14 (1.8)
Importance of religion in life 0.500
    Unimportant 14 (58.4) 77 (68.1) 465 (69.5) 556 (69.0)
    Neither important nor unimportant 5 (20.8) 13 (11.5) 99 (14.8) 117 (14.5)
    Important 5 (20.8) 23 (20.4) 105 (15.7) 133 (16.5)
Residence in the UK 0.500
    England 20 (83.3) 100 (89.3) 564 (84.2) 684 (84.8)
    Northern Ireland 1 (4.2) 3 (2.7) 12 (1.8) 16 (2.0)
    Scotland 1 (4.2) 6 (5.3) 63 (9.4) 70 (8.7)
    Wales 2 (8.3) 3 (2.7) 31 (4.6) 36 (4.5)
Disability 0.090
    No 24 (100) 101 (91.8) 576 (87.7) 701 (88.6)
    Yes (with or without paralysis) 0 (0.0) 9 (8.2) 81 (12.3) 90 (11.4)
Relative or friend with a disability 0.010
    No 22 (91.7) 86 (78.9) 448 (69.3) 556 (71.4)
    Yes (with or without paralysis) 2 (8.3) 23 (21.1) 198 (30.7) 223 (28.6)
Education 0.250
    Primary or secondary school up to 16 years 1 (4.2) 16 (14.2) 66 (9.9) 83 (10.4)
    Higher or secondary or further education (A-levels, BTEC, etc.) 4 (16.7) 30 (26.6) 148 (22.3) 182 (22.7)
    College or university degree 19 (79.2) 67 (59.2) 450 (67.8) 536 (66.9)
Employment status 0.004
    Employed full-time 15 (62.5) 70 (63.6) 363 (55.3) 448 (56.7)
    Employed part-time 1 (4.2) 17 (15.5) 131 (20.0) 149 (18.9)
    Retired 1 (4.2) 3 (2.7) 62 (9.5) 66 (8.4)
    Student 5 (20.8) 7 (6.4) 30 (4.6) 42 (5.2)
    Unemployed 2 (8.2) 13 (11.8) 70 (10.6) 85 (10.8)

Associations between demographics and healthcare and assistive technology field where BCIs should be designed, tested and used

Age was significantly associated with supporting designing, testing and using BCIs in the healthcare and assistive technology field (p = 0.009); Table 4. Specifically, a higher percentage of respondents aged 26–65 believed BCIs should be designed, tested and used in these fields compared to those aged 66 and older (26.5% vs. 6.7%). Religion was also significantly associated (p = 0.008), where a higher percentage of respondents with no religion believed BCIs should be designed, tested and used in these fields compared to those who are Christian (68.8% vs. 24.1%) or from other faiths (e.g., Dharmic faith groups at 2.5%). Furthermore, having a relative or friend with a disability was significantly associated with supporting designing, testing and using BCIs in the healthcare and assistive technology field (p<0.001); Table 4.

Table 4. Associations between demographics and health care and assistive technology field where BCIs should be designed, tested and used.

No; n (%) Yes; n (%) Total; n (%) p-value
Age 0.009
    18–25 15 (27.3) 85 (11.3) 100 (12.4)
    26–35 12 (21.8) 199 (26.5) 211 (26.2)
    36–45 15 (27.3) 198 (26.4) 213 (26.4)
    46–55 8 (14.5) 125 (16.6) 133 (16.5)
    56–65 5 (9.1) 94 (12.5) 99 (12.3)
    66 and Older 0 (0.0) 50 (6.7) 50 (6.2)
Gender 0.070
    Female 22 (40.0) 394 (52.7) 416 (51.9)
    Male 33 (60.0) 353 (47.3) 386 (48.1)
Ethnicity 0.140
    White 41 (74.6) 649 (86.9) 690 (86.0)
    Mixed/Multiple ethnic groups 1 (1.8) 10 (1.3) 11 (1.4)
    Asian/Asian British 7 (12.7) 51 (6.8) 58 (7.2)
    British Black/African/Caribbean 5 (9.1) 32 (4.3) 37 (4.6)
    Other 1 (1.8) 5 (0.7) 6 (0.8)
Religion 0.008
    Christian 14 (26.4) 177 (24.1) 191 (24.3)
    Dharmic (Hinduism, Buddhism or Sikhism) 0 (0) 18 (2.5) 18 (2.3)
    Islam 6 (11.3) 20 (2.7) 26 (3.2)
    No religion 33 (62.3) 505 (68.8) 538 (68.4)
    Other religion 0 (0.0) 14 (1.9) 14 (1.8)
Importance of religion in life 0.060
    Unimportant 35 (63.6) 521 (69.4) 556 (69.0)
    Neither important nor unimportant 5 (9.1) 112 (14.9) 117 (14.5)
    Important 15 (27.3) 118 (15.7) 133 (16.5)
Residence in the UK 0.690
    England 48 (87.3) 636 (84.7) 684 (84.8)
    Northern Ireland 0 (0.0) 16 (2.1) 16 (2.0)
    Scotland 4 (7.3) 66 (8.8) 70 (8.7)
    Wales 3 (5.4) 33 (4.4) 36 (4.5)
Disability 0.160
    No 51 (94.4) 650 (88.2) 701 (88.6)
    Yes (with or without paralysis) 3 (5.6) 87 (11.8) 90 (11.4)
Relative or friend with a disability <0.001
    No 51 (92.7) 505 (69.7) 556 (71.4)
    Yes (with or without paralysis) 4 (7.3) 219 (30.3) 223 (28.6)
Education 0.770
    Primary or secondary school up to 16 years 7 (12.7) 76 (10.2) 83 (10.4)
    Higher or secondary or further education (A-levels, BTEC, etc.) 11 (20.0) 171 (22.9) 182 (22.7)
    College or university degree 37 (67.3) 499 (66.9) 536 (66.9)
Employment status 0.110
    Employed full-time 36 (70.6) 412 (55.8) 448 (56.7)
    Employed part-time 9 (17.6) 140 (18.9) 149 (18.9)
    Retired 0 (0.0) 66 (8.9) 66 (8.4)
    Student 1 (2.0) 41 (5.6) 42 (5.2)
    Unemployed 5 (9.8) 80 (10.8) 85 (10.8)

Discussion

Summary of principal findings

Our comprehensive study on community perspectives regarding BCIs in the UK highlights a significant gap between the potential of BCI technology and public awareness or engagement with these systems. Despite nearly all respondents (98.4%) indicating they had never used a BCI, there was a notable curiosity and openness to their medical applications, particularly in aiding individuals with disabilities or neurological conditions. Additionally, our study identified significant associations between various (a) demographic factors (age, gender, ethnicity, education level, employment status), or (b) having a friend or relative with a disability, and (i) inequalities, (ii) BCI regulation, and (iii) their application in healthcare.

Respondents distinctly favoured the medical and rehabilitative applications of BCIs over non-medical uses. This was unsurprising as it aligned with a broader societal value placed on technology’s role in enhancing healthcare and quality of life for individuals facing physical challenges. For instance, the prospect of using BCIs in stroke rehabilitation or to assist those with complete or partial paralysis was met with considerable approval, highlighting the community’s recognition of BCIs as a beneficial innovation in medical technology [29]. This optimistic viewpoint was tempered by significant reservations about ethical, privacy and safety implications of BCIs, especially in non-medical contexts. Participants expressed concerns largely regarding the potential for data security risks and the long-term societal impacts of widespread BCI adoption. Such apprehensions point to an urgent need for clear regulatory frameworks and ethical guidelines to navigate the future development and implementation of BCI technologies given the rising rhetoric about Neuralink as publicised by Elon Musk [30] with various posts also appearing on X (formerly Twitter). Another critical finding was the public’s call for increased education and engagement around BCIs since the lack of familiarity with BCI technology suggests a disconnect between scientific advancements and public knowledge. Thus, whilst our sample of respondents from a cross-section of the UK community showed a cautious optimism toward BCIs, particularly in their ability to address complex medical needs, there was a clear mandate for addressing ethical concerns and enhancing public understanding of these technologies.

The mixed perceptions of BCIs among the public can be attributed to various factors, including demographic variables. Research indicates that younger individuals tend to exhibit greater openness to technological innovations, while older populations may harbour scepticism due to concerns about safety and ethical implications. For example, older and less educated individuals reported being more likely to reject invasive neurotechnologies, perceiving them as dangerous or unnatural [22]. Moreover, education plays a crucial role in shaping perceptions; individuals with higher educational attainment often demonstrate a better understanding of technology, leading to more favourable attitudes towards BCIs [31] whereas, by contrast, those with limited exposure may view BCIs as invasive or risky. Similarly, pre-existing attitudes significantly affect how different demographic groups perceive BCIs, with less educated individuals often expressing greater concerns about the risks associated with these technologies [32].

Comparison with existing literature

Our research findings are consistent with existing literature on public attitudes toward BCIs technology. A survey conducted by The Pew Research Centre among U.S. adults revealed significant insights [33] as 61% of respondents indicated they had no prior exposure to the idea of implanted computer chips in the brain. Additionally, a substantial 68% expressed concerns regarding such implants. Many U.S adults view these technological advancements as morally unacceptable, although a considerable number remain uncertain about their ethical implications. Another survey highlighted that 77% of the U.S. population supported the use of brain chips to assist individuals with paralysis, but 57% believed that the integration of brain chips could worsen socioeconomic disparities. These findings highlight the complexity of public sentiment surrounding BCI technology and ethicality [23].

Most apprehensions about BCIs expressed in our study centred on the complexity and risks associated with the surgical procedures required for implantation and removal, aligning with the conclusions of Sattler et al., who noted similar sentiments regarding the risks involved in BCI procedures [22]. As with any surgical invasive procedure, implantation carries the risk of infection, haemorrhage and iatrogenic injury [34] although chronic implantation of BCIs has yet to be studied in detail. Few studies found that in individuals with chronic brain implants, the concurrent formation of glial scar tissue at the insertion site accompanied by micro-motion of implants significantly diminishes the longevity of reliably recorded signals and reduces their quality over time [35,36]. As such, the risks associated are not clear, highlighting the necessity for monitoring the wellbeing of chronic implant patients, while also facilitating the assessment of long-term efficacy. Additionally, Intravascular implantation [37] carries a distinct set of risks which can result in a stroke or haemorrhage [34] and it is again not yet clear whether the risk of thrombosis is worrisome or whether patients may need to take antiplatelet/antithrombotic post-procedure as other neuro-interventional procedures [38].

Furthermore, aesthetic concerns may influence the decision whether to adopt a BCI device [39]. Our findings resonate with another study that identified concerns about the cosmetic visibility of BCIs, particularly among individuals with physically stigmatizing conditions like paralysis from spinal cord injury [40]. Such cosmetic barriers could significantly hinder the adoption of these devices, despite their potential for substantial functional restoration.

Our findings from the UK align with a growing body of literature that situates BCIs at the intersection of medical innovation, ethical scrutiny and privacy concerns. Consistent with previous studies, we observed a strong interest in the medical applications of BCIs, particularly in assisting patients who have lost motor and sensory functions due to stroke or spinal cord injuries [41,42]. Our study’s emphasis on ethical and privacy issues reflects cautionary perspectives raised by other researchers [14,43] who critically examined the societal implications and moral responsibilities associated with BCI advancements. This convergence of interests highlights the need for a comprehensive approach to BCI development that balances innovation with ethical considerations and public trust.

An important concern from participants is the risk of devices getting hacked. Comparable to the risks of hacking associated with other medical implants such as cardiac defibrillators [44], BCIs are associated with potential risks of neuro-hacking as well [4547]. This includes wireless manipulation of device settings that can produce potentially harmful brain stimulation affecting an individual’s cognitive, or physical characteristics, alongside the interception of signals from a brain implant to unveil sensitive personal data [46,47]. These valid concerns highlight the need for balance between innovation and ethical governance—a theme that is recurrent in both our findings and the broader academic discourse [48]—and makes the case for developing and implementing agile and resilient regulatory frameworks to ensure the privacy and safety of BCI devices. Our finding that the perceived the high costs associated with invasive BCI devices could exacerbate existing inequalities also aligns with previous studies indicating a growing concern about socio-economic disparities related to accessing BCI technology and this raises ethical concerns about equity in healthcare and technology access [49].

Our study findings notably diverge in the detailed examination of public attitudes toward non-medical uses of BCIs emphasising various apprehensions and encroachments on ethical boundaries perceived by the public. These reservations corroborate and enrich the ongoing debate around the commercialization and recreational use of BCIs as areas that are likely to be increasingly scrutinized as technology advances [17]. This is particularly relevant in the cases of enhancement whereby BCIs can be used to improve physical characteristics, which may be seen as a form of neural doping that offers the potential to surpass natural physical limits, particularly when combined with stimulatory capabilities [50].

Implications for research

The strong support for the medical application of BCIs, especially in rehabilitation for individuals with disabilities, highlights a clear direction for prioritizing research and development efforts [51] and for funding agencies and research institutions to allocate resources to these applications to maximize societal benefits. As BCIs evolve, comprehensive policies addressing potential socio-economic disparities should be developed in consultation with diverse stakeholders to reflect a wide array of societal values and concerns.

Ethical reflection and dialogue on issues like privacy and data security are crucial as society navigates the complexities of BCI technology [5254] and self-driven healthcare solutions to promote health, wellbeing and the lived experience. A participatory approach can help align technological advancements with public expectations and to help build trust and transparency. Given public concerns about data security and misuse, ethical considerations must be prioritized in BCI design and implementation whereas robust regulatory frameworks can help protect individual privacy and ensure responsible use of BCIs. Again, the adoption of co-design principles including involvement by potential users, ethicists and technologists in the design process can bridge the gap between technological development and public concerns. However, while our research indicates a desire for increased awareness about BCIs, simply raising awareness alone may not alleviate public concerns. Many respondents understood the potential benefits of BCIs in medical contexts but remained apprehensive about ethical implications and safety risks suggesting a gap between BCI technology’s potential and public confidence in its application. To bridge this gap, educational programs should provide comprehensive insights into BCI technology, addressing medical applications alongside ethical considerations, privacy issues and technological limitations. Ongoing dialogue between researchers and the public can demystify BCIs while addressing fears rooted in misunderstandings or misconceptions, whilst helping developers to proactively address ethical dilemmas.

Limitations

To our knowledge, this is the first study to comprehensively examine community perspectives on BCIs in the UK. Although the findings from our sample offer a robust reflection of societal views towards BCIs in a healthcare context, there are a number limitations that hinger generalisability of our findings including the use of a convenience sample which may introduce selection bias. Another limitation stems from the sample’s non-representative religious demography as the study sample largely included respondents who indicated they had no religion (67%) which is nearly double the national average reported in the National Census figures from 2021 in England and Wales [55] where this demographic stood at 37%. Additionally, despite the high response rate to the study, we acknowledge that nonresponse bias may still pose a concern, as the characteristics and opinions of those who did not participate could differ from those who did, potentially skewing our study findings. We acknowledge also that the cross-sectional design of our study limits our ability to establish causality between variables and hinders our capacity to track changes in public opinion over time. Further, our reliance on self-reported data may also introduce bias, as participants’ responses could be influenced by social desirability or a lack of understanding of the complex technical aspects of BCIs. Finally, although our sample is diverse, it predominantly comprised of 806 individuals with a higher than average proportion of respondents that attained a university degree, again potentially skewing the perceived enthusiasm and concerns regarding BCIs.

Conclusion

Our study expands the existing literature on BCIs by offering a focused lens on UK community perspectives. Despite a strong interest in BCIs, particularly for medical applications, ethical concerns, privacy issues and the perceived safety of BCIs are highlighted as well as the concerns associated with these technologies potentially exacerbating inequalities. These valid observations necessitate the need for clear regulatory frameworks and ethical guidelines, as well as educational initiatives to promote public understanding and trust. Involving a wide mix of stakeholders including potential users, ethicists and technologists in the design process using co-design principles can help align technological development with public concerns whilst also helping developers to proactively address ethical dilemmas.

Supporting information

S1 File. Survey (main data collection tool).

(DOCX)

pdig.0000524.s001.docx (39KB, docx)
S2 File. Checklist for Reporting Results of Internet E-Surveys (CHERRIES) was used to guide reporting.

(DOCX)

pdig.0000524.s002.docx (20.1KB, docx)
S3 File. Survey responses data file.

(XLS)

S1 Table. Respondent characteristics.

(DOCX)

pdig.0000524.s004.docx (94.8KB, docx)

Acknowledgments

The authors wish to thank Aos Alaa for his support in survey beta testing and development. Austen El-Osta, Mahmoud Al Ammouri, Sami Altalib and Azeem Majeed are supported by the National Institute for Health and Care Research (NIHR) Applied Research Collaboration (ARC) Northwest London. The views expressed are those of the authors and not necessarily those of the NHS or the NIHR or the Department of Health and Social Care.

Data Availability

The data underlying the results presented in the study are available in S3 File.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Wolpaw JR. Chapter 6—Brain–computer interfaces. In: Barnes MP, Good DC, editors. Handbook of Clinical Neurology. 110: Elsevier; 2013. p. 67–74. [DOI] [PubMed] [Google Scholar]
  • 2.Yang S, Li R, Li H, Xu K, Shi Y, Wang Q, et al. Exploring the Use of Brain-Computer Interfaces in Stroke Neurorehabilitation. Biomed Res Int. 2021;2021:9967348. doi: 10.1155/2021/9967348 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Daly JJ, Wolpaw JR. Brain-computer interfaces in neurological rehabilitation. Lancet Neurol. 2008;7(11):1032–43. doi: 10.1016/S1474-4422(08)70223-0 [DOI] [PubMed] [Google Scholar]
  • 4.Frolov AA, Mokienko O, Lyukmanov R, Biryukova E, Kotov S, Turbina L, et al. Post-stroke Rehabilitation Training with a Motor-Imagery-Based Brain-Computer Interface (BCI)-Controlled Hand Exoskeleton: A Randomized Controlled Multicenter Trial. Front Neurosci. 2017;11:400. doi: 10.3389/fnins.2017.00400 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Willett FR, Kunz EM, Fan C, Avansino DT, Wilson GH, Choi EY, et al. A high-performance speech neuroprosthesis. Nature. 2023;620(7976):1031–6. doi: 10.1038/s41586-023-06377-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Vansteensel MJ, Pels EGM, Bleichner MG, Branco MP, Denison T, Freudenburg ZV, et al. Fully Implanted Brain-Computer Interface in a Locked-In Patient with ALS. New England Journal of Medicine. 2016;375(21):2060–6. doi: 10.1056/NEJMoa1608085 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Collinger JL, Wodlinger B, Downey JE, Wang W, Tyler-Kabara EC, Weber DJ, et al. High-performance neuroprosthetic control by an individual with tetraplegia. Lancet. 2013;381(9866):557–64. doi: 10.1016/S0140-6736(12)61816-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Garcia-Cossio E, Severens M, Nienhuis B, Duysens J, Desain P, Keijsers N, Farquhar J. Decoding Sensorimotor Rhythms during Robotic-Assisted Treadmill Walking for Brain Computer Interface (BCI) Applications. PLoS One. 2015;10(12):e0137910. doi: 10.1371/journal.pone.0137910 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Xin Z, Guanghua X, Jun X, Min L, Wei P, Jinhua Z. An EEG-driven Lower Limb Rehabilitation Training System for Active and Passive Co-stimulation. Annu Int Conf IEEE Eng Med Biol Soc. 2015;2015:4582–5. doi: 10.1109/EMBC.2015.7319414 [DOI] [PubMed] [Google Scholar]
  • 10.Khan S, Aziz T. Transcending the brain: is there a cost to hacking the nervous system? Brain Communications. 2019;1(1). doi: 10.1093/braincomms/fcz015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Smith E, Delargy M. Locked-in syndrome. Bmj. 2005;330(7488):406–9. doi: 10.1136/bmj.330.7488.406 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Voity K, Lopez T, Chan JP, Greenwald BD. Update on How to Approach a Patient with Locked-In Syndrome and Their Communication Ability. Brain Sciences. 2024;14(1):92 doi: 10.3390/brainsci14010092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Elliott C, Sutherland D, Gerhard D, Theys C. An Evaluation of the P300 Brain–Computer Interface, EyeLink Board, and Eye-Tracking Camera as Augmentative and Alternative Communication Devices. Journal of Speech, Language, and Hearing Research. 2022;65(11):4280–90. doi: 10.1044/2022_JSLHR-21-00572 [DOI] [PubMed] [Google Scholar]
  • 14.Burwell S, Sample M, Racine E. Ethical aspects of brain computer interfaces: a scoping review. BMC Med Ethics. 2017;18(1):60. doi: 10.1186/s12910-017-0220-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Glannon W. Ethical issues with brain-computer interfaces. Front Syst Neurosci. 2014;8:136. doi: 10.3389/fnsys.2014.00136 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.O’Brolcháin F, Gordijn B. Ethics of Brain–Computer Interfaces for Enhancement Purposes. In: Clausen J, Levy N, editors. Handbook of Neuroethics. Dordrecht: Springer Netherlands; 2015. p. 1207–26. [Google Scholar]
  • 17.Botes MWM. Brain Computer Interfaces and Human Rights: Brave new rights for a brave new world. Proceedings of the 2022 ACM Conference on Fairness, Accountability, and Transparency; <conf-loc>, Seoul, <country>Republic of Korea</country>, </conf-loc>: Association for Computing Machinery; 2022. p. 1154–61. [Google Scholar]
  • 18.Kapitonova M, Kellmeyer P, Vogt S, Ball T. A framework for preserving privacy and cybersecurity in brain-computer interfacing applications. arXiv preprint arXiv:220909653. 2022 [Google Scholar]
  • 19.Zhao ZP, Nie C, Jiang CT, Cao SH, Tian KX, Yu S, Gu JW. Modulating Brain Activity with Invasive Brain-Computer Interface: A Narrative Review. Brain Sci. 2023;13(1). doi: 10.3390/brainsci13010134 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Jecker NS, Ko A. The Unique and Practical Advantages of Applying A Capability Approach to Brain Computer Interface. Philosophy & Technology. 2022;35(4):101. doi: 10.1007/s13347-022-00597-1 [DOI] [Google Scholar]
  • 21.Sample M, Sattler S, Blain-Moraes S, Rodríguez-Arias D, Racine E. Do Publics Share Experts’ Concerns about Brain–Computer Interfaces? A Trinational Survey on the Ethics of Neural Technology. Science, Technology, & Human Values. 2020;45(6):1242–70. doi: 10.1177/0162243919879220 [DOI] [Google Scholar]
  • 22.Sattler S, Pietralla D. Public attitudes towards neurotechnology: Findings from two experiments concerning Brain Stimulation Devices (BSDs) and Brain-Computer Interfaces (BCIs). PLoS One. 2022;17(11):e0275454. doi: 10.1371/journal.pone.0275454 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Rainie L, Funk C, Anderson M, Tyson A. AI and Human Enhancement: Americans’ Openness Is Tempered by a Range of Concerns. Pew Research Center; 2022. March. [Google Scholar]
  • 24.Prolific. London, UK [Available from: https://www.prolific.com.
  • 25.Roasoft Sample size calaculator [Available from: http://www.raosoft.com/samplesize.html.
  • 26.McHugh ML. The chi-square test of independence. Biochem Med (Zagreb). 2013;23(2):143–9. doi: 10.11613/bm.2013.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Senel E. Dharmic Religions and Health: A Holistic Analysis of Global Health Literature Related to Hinduism, Buddhism, Sikhism and Jainism. J Relig Health. 2019;58(4):1161–71. doi: 10.1007/s10943-018-0699-7 [DOI] [PubMed] [Google Scholar]
  • 28.Eysenbach G. Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34-e. doi: 10.2196/jmir.6.3.e34 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Mane R, Ang KK, Guan C. Brain-Computer Interface for Stroke Rehabilitation. In: Thakor NV, editor. Handbook of Neuroengineering. Singapore: Springer Nature Singapore; 2023. p. 1285–315. [Google Scholar]
  • 30.Musk E. An Integrated Brain-Machine Interface Platform With Thousands of Channels. J Med Internet Res. 2019;21(10):e16194. doi: 10.2196/16194 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Papanastasiou G, Drigas A, Skianis C, Lytras M. Brain computer interface based applications for training and rehabilitation of students with neurodevelopmental disorders. A literature review. Heliyon. 2020;6(9):e04250. doi: 10.1016/j.heliyon.2020.e04250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Kablo E, Arias-Cabarcos P. Privacy in the Age of Neurotechnology: Investigating Public Attitudes towards Brain Data Collection and Use. Proceedings of the 2023 ACM SIGSAC Conference on Computer and Communications Security; Copenhagen, Denmark: Association for Computing Machinery; 2023. p. 225–38. [Google Scholar]
  • 33.Funk C, Kennedy B, Sciupac E. U.S. Public Way of Biomedical Technologies to ‘Enhance’ Human Abilities. Pew Research Center; 2016. July. [Google Scholar]
  • 34.Leuthardt EC, Moran DW, Mullen TR. Defining Surgical Terminology and Risk for Brain Computer Interface Technologies. Front Neurosci. 2021;15:599549. doi: 10.3389/fnins.2021.599549 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Williams JC, Hippensteel JA, Dilgen J, Shain W, Kipke DR. Complex impedance spectroscopy for monitoring tissue responses to inserted neural implants. J Neural Eng. 2007;4(4):410–23. doi: 10.1088/1741-2560/4/4/007 [DOI] [PubMed] [Google Scholar]
  • 36.Ersen A, Elkabes S, Freedman DS, Sahin M. Chronic tissue response to untethered microelectrode implants in the rat brain and spinal cord. J Neural Eng. 2015;12(1):016019. doi: 10.1088/1741-2560/12/1/016019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Watanabe H, Takahashi H, Nakao M, Walton K, Llinas RR. Intravascular Neural Interface with Nanowire Electrode. Electron Commun Jpn. 2009;92(7):29–37. doi: 10.1002/ecj.10058 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Schirmer CM, Bulsara KR, Al-Mufti F, Haranhalli N, Thibault L, Hetts SW, et al. Antiplatelets and antithrombotics in neurointerventional procedures: Guideline update. J Neurointerv Surg. 2023;15(11):1155–62. doi: 10.1136/jnis-2022-019844 [DOI] [PubMed] [Google Scholar]
  • 39.Klein E, Nam CS. Neuroethics and brain-computer interfaces (BCIs). Brain-Computer Interfaces. 2016;3(3):123–5. doi: 10.1080/2326263X.2016.1210989 [DOI] [Google Scholar]
  • 40.Blabe CH, Gilja V, Chestek CA, Shenoy KV, Anderson KD, Henderson JM. Assessment of brain-machine interfaces from the perspective of people with paralysis. J Neural Eng. 2015;12(4):043002. doi: 10.1088/1741-2560/12/4/043002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.McFarland DJ, Wolpaw JR. Brain-Computer Interfaces for Communication and Control. Commun ACM. 2011;54(5):60–6. doi: 10.1145/1941487.1941506 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Bensmaia SJ, Miller LE. Restoring sensorimotor function through intracortical interfaces: progress and looming challenges. Nat Rev Neurosci. 2014;15(5):313–25. doi: 10.1038/nrn3724 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Clausen J. Conceptual and ethical issues with brain-hardware interfaces. Curr Opin Psychiatry. 2011;24(6):495–501. doi: 10.1097/YCO.0b013e32834bb8ca [DOI] [PubMed] [Google Scholar]
  • 44.Halperin D, Heydt-Benjamin TS, Ransford B, Clark SS, Defend B, Morgan W, et al., editors. Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses. 2008 IEEE Symposium on Security and Privacy (sp 2008); 2008. 18–22 May 2008. [Google Scholar]
  • 45.Ienca M, Haselager P. Hacking the brain: brain–computer interfacing technology and the ethics of neurosecurity. Ethics and Information Technology. 2016;18(2):117–29. doi: 10.1007/s10676-016-9398-9 [DOI] [Google Scholar]
  • 46.Denning T, Matsuoka Y, Kohno T. Neurosecurity: security and privacy for neural devices. Neurosurg Focus. 2009;27(1):E7. doi: 10.3171/2009.4.FOCUS0985 [DOI] [PubMed] [Google Scholar]
  • 47.Pugh J, Pycroft L, Sandberg A, Aziz T, Savulescu J. Brainjacking in deep brain stimulation and autonomy. Ethics Inf Technol. 2018;20(3):219–32. doi: 10.1007/s10676-018-9466-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.García LV, Winickoff DE. Brain-computer interfaces and the governance system. 2022. doi: 10.1787/18d86753-en [DOI] [Google Scholar]
  • 49.Maiseli B, Abdalla AT, Massawe LV, Mbise M, Mkocha K, Nassor NA, et al. Brain-computer interface: trend, challenges, and threats. Brain Inform. 2023;10(1):20. doi: 10.1186/s40708-023-00199-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Nijholt A, Contreras-Vidal J, Jeunet C, Väljamäe A. Brain-Computer Interfaces for Non-clinical (Home, Sports, Art, Entertainment, Education, Well-being) Applications2022. [Google Scholar]
  • 51.Mathieson Keith, Denison Tim, Winkworth-Smith C. Towards a UK Neurotechnology Strategy. 2019. [Google Scholar]
  • 52.Nijboer F, Allison B, Dunne S, Plass-Oude Bos D, Nijholt A, Haselager P, et al. A Preliminary Survey on the Perception of Marketability of Brain-Computer Interfaces (BCI) and Initial Development of a Repository of BCI Companies2011. [Google Scholar]
  • 53.Nijboer F, Clausen J, Allison BZ, Haselager P. The Asilomar Survey: Stakeholders’ Opinions on Ethical Issues Related to Brain-Computer Interfacing. Neuroethics. 2013;6(3):541–78. doi: 10.1007/s12152-011-9132-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Nijboer F, Clausen J, Allison B, Haselager P. Researchers’ opinions about ethically sound dissemination of BCI research to the public media. International Journal of Bioelectromagnetism. 2011;13:108–9 [Google Scholar]
  • 55.Office for National Statistics: Religion, En`gland and Wales: Census 2021 2021 [cited 2024 04/04]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/culturalidentity/religion/bulletins/religionenglandandwales/census2021.
PLOS Digit Health. doi: 10.1371/journal.pdig.0000524.r001

Decision Letter 0

Baki Kocaballi, Avinash Singh

1 Aug 2024

PDIG-D-24-00179

What are community perspectives regarding brain-computer interfaces? A cross-sectional study of community-dwelling adults in the UK

PLOS Digital Health

Dear Dr. El-Osta,

Thank you for submitting your manuscript to PLOS Digital Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Digital Health's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that clearly addresses the points raised during the review process.

Please submit your revised manuscript within 60 days Sep 30 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at digitalhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pdig/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Avinash Singh, PhD

Academic Editor

PLOS Digital Health

Journal Requirements:

1. We do not publish any copyright or trademark symbols that usually accompany proprietary names, eg (R), (C), or TM (e.g. next to drug or reagent names). Please remove all instances of trademark/copyright symbols throughout the text, including ® on page 5.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Digital Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: Yes

--------------------

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I don't know

Reviewer #3: Yes

--------------------

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes

--------------------

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Digital Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

--------------------

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The paper presents a comprehensive survey on public perspectives regarding Brain-Computer Interfaces (BCIs) among community-dwelling adults in the UK. The paper is well-written and easy to understand. Here are comments and suggestions to further improve the paper:

1. Discussion on Non-Response Bias: The paper reports a high response rate, but there is little discussion on the potential for non-response bias.

2. Validity of the Results: Did the authors ensure that the results of a survey accurately reflect the perspectives of the targeted population in some ways?

3. Figures and Graphical Representations: Adding figures to visually represent the results, such as bar graphs of demographic breakdowns or pie charts showing levels of support for different applications of BCIs, would make the data more accessible and easier to interpret at a glance.

Reviewer #2: The title is clear but why using question format.

The abstract is concise and provides a clear summary of the study’s objectives, methods, and key findings. However, including specific numerical results and a brief mention of the main conclusions is needed.

The study design is robust. However, the inclusion of a pilot test for the survey instrument should be mentioned to validate the questionnaire’s reliability and comprehensibility.

The results section is comprehensive. However, the narrative could benefit from a more explicit linkage of the results to the study’s aims and research questions.

The discussion needs a deeper exploration of the reasons behind the public’s mixed perceptions and the potential impact of demographic variables on attitudes towards BCIs.

The conclusion is missing specific recommendations for policymakers, researchers, and practitioners about its practical relevance.

The sampling method is not clearly described. It is unclear whether random, convenience, or purposive sampling was used.

The sample size of 806 is mentioned but there is no justification for this number. A power calculation to determine the appropriate sample size is missing.

There is no information on the validity and reliability of the questionnaire used.

The method of administration (online, face-to-face, etc.) is not specified.

The response rate is not reported, which is crucial for assessing the representativeness of the sample.

Ethical approval and informed consent procedures are not mentioned, raising concerns about the ethical rigor of the study.

The results section is primarily descriptive with limited inferential statistics. The study does not seem to leverage advanced statistical analyses to draw more robust conclusions.

There is a lack of clarity in the presentation of demographic data and their implications on the study’s findings.

Tables and figures are poorly integrated into the text and do not enhance the understanding of the results.

The reported percentages in the tables do not always add up to 100%, indicating potential errors in data presentation or analysis.

The discussion is superficial and does not critically engage with the findings.

There is a lack of comparison with previous studies, which limits the study’s contribution to the existing body of knowledge.

https://doi.org/10.1371/journal.pone.0296884

https://doi.org/10.1186/s12910-024-01062-8

Potential biases and limitations are either underexplored or ignored altogether.

The implications of the findings for future research, policy, and practice are not adequately discussed.

The conclusion is weak and does not effectively summarize the main findings or their significance.

Recommendations for future research are vague and lack specificity.

The overall structure of the paper lacks coherence, making it difficult to follow the logical flow of arguments.

Language and grammar issues are present throughout the manuscript, which detracts from the professionalism of the paper.

There is a noticeable absence of critical engagement with the literature and a lack of depth in the analysis.

The study's contribution to the field is minimal due to its methodological flaws and superficial treatment of the topic.

Reviewer #3: This is a very investing study and I was very happy to see that the authors directly engage with some of the concerns that the public might have about BCI and related applications. I think that the conclusions reached in the study are very interesting and show a direct engagement with these issues. I recommend publication and only have smaller suggestions.

First, I wonder if the authors could say a bit more on the consequences of their findings for research and perhaps their research: what should be done considering the reservations about the ethical, privacy and safety implications? Could a path towards co-design or ethically-informed design be developed?

Secondly and relatedly, the paper seems to imply that the identified issues are due to and will be resolved by more awareness and knowledge about the technology. I am not so sure about this, as some of the concerns seem to be aligned with how the technology works or at least could be developed. I wonder if the authors could say more about the idea of a gap between the potential of the technology and public awareness – to me it seems that the public was actually mostly aware of the potential of the technology and still concerned.

--------------------

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

--------------------

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLOS Digit Health. doi: 10.1371/journal.pdig.0000524.r003

Decision Letter 1

Baki Kocaballi, Avinash Singh

20 Dec 2024

Community perspectives regarding brain-computer interfaces: a cross-sectional study of community-dwelling adults in the UK

PDIG-D-24-00179R1

Dear Dr. El-Osta,

We are pleased to inform you that your manuscript 'Community perspectives regarding brain-computer interfaces: a cross-sectional study of community-dwelling adults in the UK' has been provisionally accepted for publication in PLOS Digital Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow-up email from a member of our team. 

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact digitalhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Digital Health.

Best regards,

Baki Kocaballi

Section Editor

PLOS Digital Health

***********************************************************

Additional Editor Comments (if provided):

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

Reviewer #3: All comments have been addressed

**********

2. Does this manuscript meet PLOS Digital Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I don't know

Reviewer #3: I don't know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Digital Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Authors have addressed my comments.

Reviewer #2: I believe it may be beneficial to consider postponing the publication of this paper until the interview phase is complete. By integrating both the quantitative survey results and the qualitative interview findings into a single mixed-methods study, you can provide a more comprehensive analysis of the community’s perspectives. This approach would not only enhance the depth of your findings but also help avoid issues related to salami slicing in publication and dissemination of knowledge.

Thank you for your response regarding the comparison with previous studies. I have reviewed the revised manuscript, and it appears that the comparison with the literature you mentioned is not adequately addressed. While it is not mandatory to use the specific studies I suggested if they are not directly relevant, the key point is to contextualize your findings within the broader literature on ethical considerations from the perspectives of healthcare providers. Additionally, considering studies from regions that differ significantly from the UK or US could provide valuable insights and enhance the contribution of your work. I encourage you to expand this section to better illustrate how your findings align or contrast with existing research.

The survey may not fully capture the depth of participants' understanding of BCIs, as only a small percentage reported comprehensive knowledge. While demographic data were collected, their influence on perceptions was not thoroughly explored, which could lead to oversimplified conclusions.

Although ethical implications are mentioned, there is insufficient depth in exploring participants' views on these concerns such as the notion of "playing God".

The statistical methods employed may not adequately address potential confounders or interactions between demographic variables.

Some results, particularly in tables and figures, lack clarity and would benefit from more detailed explanations in the text. Clearer organization, especially grouping related findings together, could enhance readability and coherence.

The overrepresentation of individuals with higher education and the disproportionate number of respondents identifying as non-religious may limit the applicability of your results.

I noticed several grammatical errors, including spacing issues and inconsistencies in in-text citations.

Reviewer #3: All comments addresses, I reccomend publication.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Survey (main data collection tool).

    (DOCX)

    pdig.0000524.s001.docx (39KB, docx)
    S2 File. Checklist for Reporting Results of Internet E-Surveys (CHERRIES) was used to guide reporting.

    (DOCX)

    pdig.0000524.s002.docx (20.1KB, docx)
    S3 File. Survey responses data file.

    (XLS)

    S1 Table. Respondent characteristics.

    (DOCX)

    pdig.0000524.s004.docx (94.8KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pdig.0000524.s005.docx (33.8KB, docx)

    Data Availability Statement

    The data underlying the results presented in the study are available in S3 File.


    Articles from PLOS Digital Health are provided here courtesy of PLOS

    RESOURCES